Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China flag China · Delayed Price · Currency is CNY
39.95
+2.72 (7.31%)
Apr 28, 2026, 3:00 PM CST
157.08%
Market Cap 27.24B
Revenue (ttm) 1.66B
Net Income (ttm) 297.84M
Shares Out 733.37M
EPS (ttm) 0.40
PE Ratio 99.88
Forward PE 78.72
Dividend 0.12 (0.32%)
Ex-Dividend Date Aug 14, 2025
Volume 60,830,138
Average Volume 39,219,016
Open 37.79
Previous Close 37.23
Day's Range 37.74 - 40.95
52-Week Range 15.12 - 45.95
Beta 0.92
RSI 63.73
Earnings Date Mar 30, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s... [Read more]

Sector Healthcare
Founded 1995
Employees 2,649
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603127
Full Company Profile

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial Statements

News

There is no news available yet.